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A B S T R A C T   
For medical biomaterials, xyloglucan dispersions can form films or gels to be applied as a wound dressing. For 
this purpose, the structural characterization of xyloglucan dressing (XG) and xyloglucan dressing containing 0.5 
mg/mL of concanavalin A (XGL) was performed. The lectin release capacity and stability, cytotoxicity, and pro- 
wound healing effects were also investigated. XG and XGL films were prepared by mixing 0.5 % (w/v) xyloglucan 
with 0.3 % (v/v) glycerol. The ConA incorporated in the xyloglucan dressing maintained its biological activity for 
fourteen days in a controlled-release manner. The films were non-toxic, homogeneous, flexible, and accelerated 
the wound contraction compared with the control group, promoting less infiltration of inflammatory cells, 
angiogenesis, remodeling, and early epithelization. The films also alleviate the inflammation phase by reducing 
the production of pro-inflammatory cytokines (IFN-γ, TNF-α, IL-1β, IL-6, and IL-12), especially the XGL film, 
which promoted the up- and down-regulation of important proteins associated with the wound repair. All these 
findings suggest that XG and XGL films may represent a good therapeutic approach for wound healing 
applications.   
1. Introduction 
The wound healing process takes place to restore the anatomical and 
functional integrity of the tissue after a physical or thermal wound. For 
this, the organism makes use of a sequence of biochemical and cellular 
events in response to tissue damage. These events are divided into the 
following phases: inflammatory, proliferation or granulation of the 
extracellular matrix (ECM), and ECM remodeling for scar formation 
(Kordestani, 2019). In this process, time is an important aspect and re-
searchers in this field are looking-for the development of new products 
and therapies that can accelerate the healing and given a better quality 
to the healed skin (Ajith et al., 2021; Picone et al., 2019). 
Xyloglucans (XG) from the primary cell walls of monocotyledons 
seeds (Tamarindus indica, Copaifera langsdorffii, and Hymenaea courbaril) 
(Hayashi & Kaida, 2011) are high molecular weight neutral branched 
polysaccharides. Its chemical structure has a cellulose-like backbone, 
composed of β-glucosyl ring units with ribbon-like conformation, where 
single units of xylose and galactose substituents form a part of the 
branches (Nishinari et al., 2021). Here we have used the XG (≥ 500 kDa) 
from Hymenaea courbaril var. courbaril seeds with a central backbone 
composed by 4-linked β-glucose branched at position 6 with 
non-reducing terminal units of α-xylose or β-galactose-(1→2)-α-xylose 
disaccharides (Arruda et al., 2015). Xyloglucans from different sources 
were extensively used in the production of biomaterials, especially in 
pharmaceuticals, as drug delivery devices (Farias et al., 2018; Kulkarni 
et al., 2017; Pardeshi et al., 2018). In addition, it was reported that this 
polymer has anti-inflammatory and immunomodulatory properties and 
synergistic effects with other anti-inflammatory biomolecules when 
used in topical and mucosal wound dressings (Zhou et al., 2020). 
Lectins are proteins and glycoproteins which could bind to specific 
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monomers either a soluble carbohydrate or the carbohydrate portion of 
a glycoconjugate. These interconnective proteins are present in both 
plants and animals and play roles in various biological processes, 
including immunomodulation and cell adhesion (Coelho et al., 2017; 
Santos et al., 2014). Concanavalin A (ConA), a lectin from Canavalia 
ensiformis seeds, possess immunomodulatory effects as a mitogenic 
agent for lymphocytes cell, activating the nuclear factor of activated T 
cells, an important transcription factors in the activation of immune 
system (Bemer & Truffa-Bachi, 1996; Dwyer & Johnson, 1981). 
The advances in tissue engineering and regenerative medicine has 
transformed the wound care world into advanced technological matrices 
that not only prevent infections, but also improve the process of dermal 
and epidermal tissue recovery, in addition to modulate the expression of 
growth factors involved in the healing process (Ajith et al., 2021). 
Polysaccharides are the most explored natural polymers in the prepa-
ration of biomaterials for wound care. For example, cellulose (Liu et al., 
2020), chitosan (Shivakumar et al., 2021), and galactomannans (Albu-
querque et al., 2017; Yadav & Maiti, 2020), have been extremely 
explored in the development of intelligent wound dressings; however, 
XG based matrix reported so far are few (Ajovalasit et al., 2018a; Ajo-
valasit et al., 2018b; Andrade et al., 2021; Picone et al., 2019). 
The immobilization of ConA into XG, sodium alginate, and gal-
actomannan membranes was previously reported in the development of 
biosensors for Dengue viruses antigens (Pereira et al., 2008; Valenga 
et al., 2012). In what concerns the best of our knowledge, there are no 
previous reports on XG/ConA based wound dressings; its application in 
wound care, the characterization of the dressing, and its influence on the 
healing process is also unknown and constitutes an important goal for 
exploration in the biomedical and medical fields. 
This study aimed at the production and the structural and bioactive 
characterization of xyloglucan membranes obtained from H. courbaril 
seeds with or without the incorporation of ConA. For this, an extensive 
study was performed in which we evaluated the profile of the drug 
release, the stability and cytotoxicity of the films, and their ability to 
improve the quality of the new tissue formed on experimental wounds in 
mice. 
2. Material and methods 
2.1. Wound dressing preparation 
The XG (81±7 % of purity, MW≥ 500 kDa, with a central backbone 
composed by 4-linked β-glucose branched at position 6 with non- 
reducing terminal units of α-xylose or β-galactose-(1→2)-α-xylose di-
saccharides) contained in Hymenaea courbaril var. courbaril seeds was 
obtained according to Arruda et al. (2015). 
The wound dressings were prepared by mixing (200 rpm) a XG so-
lution (0.5% w/v) with glycerol 0.3% (v/v) for two hours at 25◦C. The 
pH was adjusted to 5.8 with 1.0 M NaOH solution. Commercial conca-
navalin A (ConA from Sigma Aldrich, USA), ConA conjugated with 
fluorescein isothiocyanate (ConA-FITC), and ConA conjugated with gold 
(ConA-Au) were prepared at 0.5 mg/mL concentration. After, each 
protein was mixed (200 rpm) with the XG solution at 25◦C for 30 min. 
The concentration of ConA incorporated into the filmogenic solution 
was based on the study carried out by Andrade et al. (2021), where the 
incorporation of the Cratylia mollis lectin (Cramoll) into a xyloglucan 
matrix was performed; considering that Cramoll is a glucose/mannose 
specific lectin, as well as ConA, we used the same concentration reported 
in the literature. Afterwards, 15 mL of each filmogenic solution were 
placed in acrylic plates (90 mm × 15 mm) and dried at 37 ◦C for 24 h. 
Dried wound dressings, named Xyloglucan (XG), Xyloglucan-ConA 
(XGL), Xyloglucan-ConA-FITC (XGL-FITC), and Xyloglucan-ConA-Au 
(XGL-Au) were stored in desiccators at 25◦C and 54.0% of relative hu-
midity (maintained by Mg(NO3)2.6H2O saturated solution) until further 
analysis. 
2.2. Characterization of the wound dressings 
FTIR spectra of XG and XGL were obtained by infrared spectrometer 
(VERTEX 70, Bruker Optics, USA), using Attenuated Total Reflectance 
(ATR) mode. The analysis conditions for scanning the spectra were 4 
cm− 1 of resolution, co-adding 128 scans, and frequency range 4000–500 
cm− 1. 
The fluorescent pattern of XGL-FITC was evaluated by green fluo-
rescence mode using a DMI 4000 B fluorescence microscope (Leica 
Microsystems, Wetzlar, Germany). The band-pass and the long-pass 
(488 nm) filters were used respectively to excite and to collect the 
fluorescence, allowing the visualization of the lectin incorporated into 
the xyloglucan wound dressing. All images were acquired with a color 
Pixelfly camera (PCO-TECH Inc., Romulus, MI, USA). The analysis of the 
morphology and microstructure of XGL-Au, immobilized on copper 
grids, was observed by a transmission electron microscopy (FEI Mor-
gagni 268D 40-100kV, PHILIPS, EUA). 
The measurements of the water vapor permeability (WVP) were 
carried out gravimetrically as described by Souza et al. (2015). Oxygen 
permeability (O2P) was determined based on the ASTM D 3985-17 
(ASTM, 2017). Tensile strength (TS) and elongation-at-break (EB) 
were measured with an Instron Universal Testing Machine (Model 4500, 
Instron Corporation, USA) according to the ASTM D882-10 (ASTM 
2010). Three measurements were obtained for each sample. 
2.3. In vitro assessment of ConA release, bioactive stability, and 
cytotoxicity of the dressings 
The bioactivity of ConA lectin was evaluated by the Hemagglutina-
tion Activity (HA) assay, which was defined as the lowest lectin dilution 
that showed complete hemagglutination of rabbit blood cells (Correia & 
Coelho, 1995). Samples of XG and XGL were solubilized in NaCl 0.9 % 
until reach a final ConA concentration of 0.0 and 0.5 mg/mL, respec-
tively. Free ConA (0.5 mg/mL) was used as standard. 
The ConA release assay was performed by incubating XGL into 15 mL 
of Citrate-Phosphate Buffer solution 0,1 M, pH 6.0 for 96 h. At certain 
time intervals, 1.0 mL of samples were taken from the buffer solution 
and 1.0 mL of fresh buffer were added to the system to keep the volume 
of release medium constant. The samples were evaluated by HA and 
protein concentration (Bradford, 1976). 
To assess the mechanism of ConA release, experimental data were 
fitted to four specific kinetic models (Souza et al., 2015; Korsmeyer & 
Peppas, 1981): 
Zero order : Qt = Q0 + K0t (1)  
First order : InQt = InQ0 + K1t (2)  
Higuchi : Qt = KHt1/2 (3)  
Korsmeyer − Peppas : Qt = Kktn (4)  
where: Qt is the amount of ConA released over time; Q0 is the amount of 
ConA released at time 0; K0, K1, KH e Kk are kinetic constants and n is the 
release exponent. 
The stability of XGL during 97 days of storage was determined by 
evaluating the HA of the wound dressing at 4 and 30◦C. In determinate 
times between 0 and 97 days, samples of XGL at each temperature of 
storage were solubilized in 15 mL NaCl 0.9% and submitted to HA 
evaluation. ConA at 0.5 mg/mL concentration was used as positive 
control of the HA assay. 
To determine the nontoxic concentration of XG e XGL, splenocytes 
from BALB/c mice (6 × 105 cells/well) were cultured in ninety-six well 
plate in RPMI 1640 media supplemented with 10.0% fetal bovine serum 
and 50 μg/mL of gentamycin. Cells were incubated in the presence of 3H- 
thymidine during 24 h at 37
◦
C and 5.0% CO2. According to the 
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treatment, cells were grouped on: treated with dissolved XG and XGL 
dressings in RPMI media (1, 5, 10, 25, 50, and 100 μg/mL), negative 
control group (cells incubated with 3H-thymidine), and positive control 
group (cells treated with saponin and incubated with 3H-thymidine). 
After 24 h, the cultures were harvested using a cell harvester to deter-
mine the 3H-thymidine incorporation in a beta radiation counter. The 
viability of the cells was determined by the incorporation of 3H-thymi-
dine in XG and XGL treatments, and the 50% cytotoxic concentration 
(CC50) was defined as the wound dressing concentration that reduced 
50% of viable cells when compared with the negative control (Pereira 
et al., 2004). 
2.4. In vivo wound healing study 
Male BALB/c mice (Mus musculus) (n=45) with 12 weeks of age 
weighing (37.0±1.5 g), were supplied by the bioterium of the Fundação 
Oswaldo Cruz (FIOCRUZ) - Instituto Aggeu Magalhães (IAM), and kept 
in the experimental surgery laboratory of the Keizo Asami Immunopa-
thology laboratory - UFPE. Each animal was kept in an individual cage, 
under controlled environmental conditions (12 h light/dark cycle, 
temperature 23±1◦C and humidity of 55.0±10.0%) with free access to 
water and food. The animals were carefully monitored and maintained 
according to the ethical recommendation of the Brazilian College of 
Animal Experimentation (COBEA). This study was approved by the 
Ethics Committee on the Use of Animals (CEUA-UFPE), process N◦. 
23076.029229/2011-17. 
The animals were divided into three groups (n=15/group) and 
submitted to surgical experiments under intraperitoneal anesthesia with 
10.0 mg/kg of xylazine hydrochloride (2.0% w/v) and 115.0 mg/kg of 
ketamine hydrochloride (10.0% w/v). A standard wound (0.8 cm in 
diameter) was performed using surgical scissors to remove the 
epidermal and dermal layers of the dorsal animals skin. The treatment of 
each lesion was performed just once on the day of surgery by the 
application of the XG and XGL dressings at the wound area; the control 
group (C) was treated just once with 100 µL of 0.15M NaCl. 
Three animals from each experimental group at 0th, 3rd, 6th, 10th, and 
14th day after the surgical procedure were anesthetized and have the 
wound areas measured with a digital caliper. The wound area was 
calculated as follows: A=πRr (A=Wound area; R and r the main and 
secondary wound radii, respectively). The calculation of the degree of 
contraction (D) was expressed as percentage using the equations of 
(Ramsey, 1995), D=100x(Ai-Af)/Ai (Ai=initial wound area; Af=wound 
area at the euthanasia). The results were expressed as media of three 
measurements±standard deviation. Then, the skin around the wound 
area was removed and transferred to histological cassettes and incu-
bated in 4.0% (v/v) formaldehyde in 0.01 M PBS buffer pH 7.2, for a 
maximum period of 48 h. Thereafter, the formalized tissues were 
included in paraffin and, after microtomy, stained with 
Hematoxylin-Eosin (HE) and Masson’s Trichrome (MT). 
Blood samples (1 mL) were also collected from the anesthetized 
animals using the cardiac puncture technique. At the end, the animals 
were euthanized with lethal doses of sodium Pentobarbital (200 mg/kg) 
intraperitoneally. The obtained serum was used for the cytokine mea-
surements and proteomics analysis. Milliplex cytokines immunoassay 
kits (Genese Produtos Diagnósticos Ltda, São Paulo, Brazil) were used 
for the measurements of interferon-γ (IFN-γ), tumour necrosis factor 
(TNF-α), interleukin 1β (IL-1β), interleukin 6 (IL-6), and interleukin 12 
(IL-12). The tests were performed in triplicate according to the manu-
facturer’s protocol. Data were collected using the MagPix Analyzer 200 
flow cytometer (Luminex, Austin, USA) and the analysis was performed 
using Xponente software version 4.2. A four-parameter regression for-
mula was used to calculate sample concentrations from standard curves. 
2.5. Serum proteomics 
Frozen serum samples from the animals of the treated groups (C, XG 
and XGL) were subjected to the trizol extraction method, according to 
the manufacturer’s instructions Trizol kit (Invitroge®). The total pro-
teins were quantified according to the instructions of the 2D Quant Kit 
(GE Healthcare, Piscataway, NJ, USA), using 2.0 mg/mL of bovine 
serum albumin (BSA) as standard. The serum proteins in the 2D gels 
were visualized by staining with Coomassie Brilliant Blue (CBBR250) 
according to Candiano et al. (2004). Gel images were acquired with a 
scanning resolution of 300 dpi, then analyzed with a ImageMaster 2D 
Platinum 7.0 software (GE Healthcare, Piscataway, NJ, USA). The 
quantity of each spot was normalized by the total intensity of valid spots. 
Serum protein spots were considered differentially expressed if the in-
tensity changed statistically on different days. 
The digestion of serum proteins in the 2D SDS-PAGE gel was per-
formed as the method described by Shevchenko et al. (2007) with some 
modifications: trypsin solution (25 ng/mL) was used and the reduction 
and alkylation steps were omitted. The peptides were dissolved in 10 µL 
of 0.1 % TFA. The saturated solution (4.0 mg/mL) of 
alpha-cyano-4-hydroxycinnamic acid (CHCA) in 50.0% (w/v) ACN and 
0.3% (w/v) TFA were mixed with an equal amount of the sample and 
placed on the Anchor Chip 800/384 plate (Bruker Daltonic GmbH), and 
left to dried in laminar air flow for recrystallization. For calibration, 0.5 
µL of standard calibration peptide (Bruker Daltonik GmbH) was mixed 
with 0.8 µL of CHCA matrix and recrystallized as well. The samples were 
analyzed on a MALDI TOF/TOF mass spectrometer (Ultraflex III, Bruker 
Daltonics) in reflectron mode. 
Mass spectra analysis was performed using the MASCOT search tool 
(Matrix Sciences, UK). Research was carried out using a mass tolerance 
set of 100 ppm and an +1-peptide loading. Trypsin was defined as a 
proteolytic enzyme with allowed lost cleavage. Carbamidomethylation 
of cysteine residues was defined as fixed modification and oxidation of 
methionine residues as the variable modification. MSDB, NCBInr, and 
Uniprot/Swissprot (release 15.2) databases were used to identify serum 
proteins from mice with the MASCOT server (Matrix Science, UK), 
available online. The identity of the serum proteins was considered 
significant if at least ten peptides matched those in the database, with a 
MASCOT peptide ion score greater than 85. The databases used were 
released in August 2006 for MSDB, October 2007 for NCBInr and May 
2009 for UniProt/Swissprot. 
2.6. Statistical analysis 
All static analysis was performed using Graph Pad Prism software 
(version 6, 2012, USA). Student’s t-test (p<0.05) was used in the char-
acterization tests of the dressings. For the calculation of the area of 
contraction of the lesions and the analysis of the cytokine profile, was 
used analysis of variance (p<0.05), followed by the Tukey and Bonfer-
roni tests, respectively. 
3. Results and discussion 
3.1. Wound dressing characterization 
Infrared-ATR spectra of XG and XGL are depicted in Fig. 1. The 
incorporation of lectin in polysaccharide films could be attributed to O- 
H stretching of the polysaccharide bound to the main functional groups 
of the lectin (Ockman, 1981). This can be noted in the major band at 
approximately 3350 cm− 1, corresponding to the hydrogen bounds be-
tween the ConA and the xyloglucan polymeric chain. The same obser-
vation has been reported in the literature for protein incorporation into 
polysaccharide films (Kanmani & Rhim, 2014). 
The three other important bands in XGL are located at 3240 cm− 1 
(Amide A), 1631 cm− 1 (Amide I), and 1580 cm− 1 (amide II). The 
chemical groups stretch responsible for these absorptions are the N-H, 
C=O, and a combination of N-H deformation and C-N stretch, respec-
tively (Ockman, 1981). Among these three bands, the most interest is the 
amide I absorption, since its frequency is a measure of β-pleated sheet 
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conformation in the secondary structure of proteins (Kong & Yu, 2007), 
proving that ConA was entrapped with success inside the xyloglucan 
dressing. 
Fluorescence microscopy images of XG and XGL-FITC are shown in 
Fig. 2 (A and B, respectively). XG did not show fluorescence, whereas 
XGL-FITC emitted fluorescence, allowing the visualization of the ConA 
distribution in the dressing. Jó et al. (2010) demonstrated that the 
critical concentration of a protein into a xyloglucan (from Tamarindus 
seeds) solution varies from 0.038 to 0.09 mg/mL, which is much lower 
than the 0.5 mg/mL used in this study. Despite this, ConA was homo-
geneously distributed through the microstructure of the XGL-FITC. 
TEM images of the xyloglucan film labeled with ConA-Au (XGL-Au) 
are shown in Fig. 2 (C and D). It was possible to observe that the XG are 
made of micro-aggregates (small spherical bodies) with 1.0-2.0 μm. 
These micro-aggregations could be possible due to the xyloglucan so-
lution characteristics of partial water-solubility (Jó et al., 2010). The 
individual macromolecules of xyloglucan show a balance between hy-
drophobic and hydrophilic centers and the substantial chain stiffness of 
the cellulose-like backbone facilitates intermolecular interactions, witch 
trend to fail in fully hydration; consequently, aggregate species remain 
present even in very dilute solutions (Jó et al., 2010; Picout et al., 2003). 
It was also possible to observe that ConA-Au of the XGL-Au was uni-
formly distributed inside the micro-aggregates. As noted by Zhang et al. 
(2013), the presence of ConA-Au was characterized by the presence of 
small electrodense spheres. 
The humid environment prevents dehydration of the tissue, which 
helps in reepithelization, accelerates angiogenesis, increases the degra-
dation of dead tissue and fibrin, and enhances the interaction of growth 
factors with the epithelial cells in the wound. Dressings that promote 
greater moisture retention are associated with less clinical infections, 
greater patient comfort, and reduced scarring (Kaczmarek et al., 2020; 
Singh, Sharma, & Dhiman, 2013). As can be seen in Table 1, XG are 
permeable to water vapor, with no significant changes (p>0.05) even 
with the incorporation of ConA into the matrix. The values found are like 
those described by Albuquerque et al. (2017) for galactomannan films 
(5.60 ± 0.39 10− 7 g h− 1 m− 1 Pa− 1). 
XG and XGL can provide adequate O2 supply to the wound bed 
(Table 1), which is a prerequisite for tissue homeostasis, energy pro-
duction, cell membrane maintenance, mitochondrial function, and cell 
repair (Singh & Pal, 2012). The incorporation of ConA in 
xyloglucan-based dressings did not statistically affect (p <0.05) these 
properties. Souza et al. (2015) reported similar results of oxygen 
Fig. 1. Infrared-ATR spectra of xyloglucan (XG) and xyloglucan containing 
ConA (XGL) dressings. 
Fig. 2. Fluorescence and transmission electron microscopy images of the dressings. (A) xyloglucan dressing (XG); (B) xyloglucan dressing containing ConA-FITC 
(XGL-FITC); (C and D) xyloglucan dressings containing ConA-Au (XGL-Au). 
Table 1 
Values of water vapor permeability (WVP), oxygen permeability (O2P), thick-
ness, tensile strength (TS), and elongation at break (EB) obtained from the 
xyloglucan (XG) and xyloglucan containing ConA (XGL) dressings.  
Properties XG XGL 
Gas barrier properties   
WVP (10− 7.g.h− 1.m− 1.Pa− 1) 5.50 ± 0.21a 6.02 ± 0.86a 
O2P (10− 13.g.m.Pa− 1.s− 1.m− 2) 6.03 ± 0.85a 6.41 ± 1.40a 
Mechanical properties   
TS (MPa) 7.10 ± 0.42a 10.28 ± 0.33b 
EB (%) 29.88 ± 1.32a 29.37 ± 1.45 a 
Thickness 0.039±0,005 b 0.046±0.008a 
abDifferent superscript letters in the same line indicate a statistically significant 
difference (t test, p<0.05). Data were expressed as media±standard deviation. 
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permeability for chitosan-based films containing quercetin 
(7.47±0.50.10− 13.g.m.Pa− 1.s− 1.m− 2). 
Considering the thickness of the films, it is possible to observe that 
increasing values of thickness generally leads to increased gas transfer 
resistance (Pérez-Vergara et al., 2020). As expected, the addition of 
conA to the filmogenic solution led to the formation of thinner films 
(p>0.05). In XGL, we can observe that even with a slight tendency to 
increase in WVP and O2P (Table 1), these were not significant (p<0.05). 
We also believe that ConA led to a small increase in the available volume 
in the polymer matrix, thus favoring the gases penetration. Gutierrez 
et al. (2015), when evaluating films based on cush-cush yam and cassava 
starches observed a slight tendency to increase the films permeability by 
increasing the thickness. The barrier properties of polysaccharide based 
films are complex parameters that depend not only on the thickness of 
the films but also on the degree of polymeric crosslinking and polymer 
crystallinity (Siracusa, 2012). 
It has been reported that ideal wound dressings must be strong 
enough to withstand handling and replacement, as well as elastic, to 
keep up with skin movements (Naseri-Nosar et al., 2017; Üstündağ Okur 
et al., 2019). The mechanical properties shown that the XG have low TS, 
however, these values were higher than the lowest acceptable value of 4 
MPa for polymeric films (Rodrigues et al., 2018). Different formulations 
of films based on xyloglucan, extracted from Tamarindus indica seeds, 
showed TS values between 9.14–20.70 Mpa (Santos et al., 2019). The 
values obtained for EB are in accordance with those described in the 
literature for films based on xyloglucan and denote the formation of 
elastic films (Rodrigues et al., 2018; Santos et al., 2019). There were no 
differences (p <0.05) in EB between XG and XGL. However, the addition 
of ConA to the xyloglucan dressing led to the formation of stronger films, 
with a higher TS value, probably due to the formation of a more stable 
polymer matrix. These results corroborate the FTIR results where the 
xyloglucan chains interact with ConA through hydrogen bonds, thus 
leading to stronger dressings. 
3.2. In vitro assessment of ConA release, bioactive stability, and 
cytotoxicity of the dressings 
The ConA release rate from XGL can provide information about the 
Fig. 3. ConA release rate (A), and hemagglutinating activity stability (B) from free ConA and xyloglucan dressings containing ConA (XGL) stored at 4 ◦ and 30◦C. The 
results were expressed as the mean±standard deviation (n=3). 
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ideal time for dressing changes. In Figure 3A it is possible to observe that 
CoA is released from the XGL in two stages: a faster release 
(36.87±2.49%) in the first 8 hours followed by a slower release that 
reaches equilibrium within 72 h (95.67±3.92%). At the end of the 
process (96 h), there was an almost total dissolution of the XGL matrix in 
the aqueous medium and, consequently, the release of all immobilized 
ConA. When a solvent diffuses into a polymeric film, the mobility of the 
polymeric network gradually increases (matrix relaxation), allowing the 
entrapped macromolecules to solubilize and migrate through the 
swollen matrix (Üstündağ Okur et al., 2019). In addition, the lectin 
bioactivity was determined throughout the release test (for the first 
72h), which remained stable with a HA of 1024, which did not differ 
from the control solution (free ConA 0.5 mg/mL). 
Regarding the release kinetics, the parameter used to define the most 
adequate model was the evaluation of the correlation coefficient (R2). As 
can be seen in table 2, the Korsmeyer and Peppas model (Korsmeyer & 
Peppas, 1981; Korsmeyer et al., 1983) was more adequate (R2 of 0.98.). 
This model is used to assess drug release from polymeric dosage forms, 
where the release mechanism is not well known or when another 
anomalous type of release may be involved (Munday & Cox, 2000; 
Sujja-areevath et al.1998). The “n” release exponent value obtained was 
0.58, thus achieving the pattern associated with an anomalous mecha-
nism of release, non-Fickian model. Based on this result, in addition to 
the profile observed in the release curve (Figure 3A), we hypothesize 
that the ConA release occurs from the combination of three apparently 
independent processes: first, a small burst release (probably due to the 
presence of ConA in the film surface); second, due to swelling and 
erosion of the matrix; and finally, because to the Fick’s laws. 
The anomalous release process was also described for matrices based 
on xanthan, karaya and locust bean gum, with “n” values of 0.70, 0.73 
and 0.77, respectively (Sujja-areevath et al.,1998). Corroborating with 
our results, the kinetic behavior of streptomycin release in biodegrad-
able matrices based on xyloglucan and chitosan (1:1) also showed 
anomalous behavior with “n” of 0.89 and R2 of 0.85 (Simi & Abraham, 
2010). 
The stability of ConA in the XGL in relation to free ConA, stored at 
4◦C and 30◦C, was evaluated for 48 days measuring its hemagglutinating 
activity (Figure 3B). Although ConA activity has decreased significantly 
over storage time, the activity of immobilized ConA remained un-
changed for a longer period (34 days at 4◦C), suggesting that the 
incorporation of ConA in the xyloglucan dressings can effectively 
improve its stability. The increase in bioactive activity time of macro-
molecules after immobilization in polymeric films has also been 
described by Chen et al. (2020b), which developed functional wound 
dressings containing bromelain immobilized. In Figure 3B was also 
showed that the increase in storage temperature has a negative influence 
on the stability of ConA. While the immobilized ConA stored at 4◦C 
maintained 100% of its activity with 10 days of storage, those that were 
stored at 30◦C showed only 6.5% of its activity in the same period. Thus, 
the ideal temperature for the storage of the XGL was 4◦C. 
Before the in vivo tests, new dressings of any kind need to be tested in 
vitro to ascertain that cell viability was not affected. Concerning the 
cytotoxicity assay, XG showed no signal of cytotoxicity in all concen-
trations, whereas the XGL up to 50 µg/mL showed no cytotoxicity and 
the 100 µg/mL concentration was capable to maintain 88.0% of the 
splenocytes viable. In view of this, the CC50 was related to higher than 
100 µg/mL concentration of the XGL. Xyloglucan extracted from tama-
rind was tested for cytotoxicity using intestinal epithelial cell-6 and 
showed non-toxicity and a cytoprotecting pattern for 125, 250, and 500 
µg/mL of polysaccharide concentrations (Periasamy et al., 2018). Ajo-
valasit et al. (2018b) reported a moderate cytotoxicity about 75 % of 
viability of A549 epithelial cells for xyloglucan films (4.0 and 8.0 
mg/mL). 
Anterior reports shown that ConA with concentrations inferior to 0.1 
mg/mL showed no cytotoxicity to hepatocytes, but concentrations su-
perior to 0.4 mg/mL were cytotoxic (Miyagi et al., 2004). Considering 
that only 46% of the ConA was released from XGL in the first 24 h, which 
is approximately half of the toxic concentration of ConA, it is remarkable 
that the concentration of the lectin released from XGL is no toxic. 
3.3. Wound healing analysis 
The wound area retraction rate and the evolution of wound area are 
shown at the Figure 4. In the macroscopic findings, a significant dif-
ference (p<0.05) was observed in terms of the contraction of the lesion 
after the sixth day, where the XGL group presented an area of 0.08±0.01 
cm2 and the groups C and XG still had areas of 0.21±0.03 cm2. 
On the tenth day for the XGL group, the wound has already 
completely closed, while the C and XG groups still had an area of 
0.03±0.01 cm2. Sheets containing 3.0% (w/v) of xyloglucan applied in 
deep skin wounds showed similar results to the XG and XGL of this work 
reducing the wound area for about 40.0% (Hirose et al., 2019). Histo-
logical evaluation of the healing process of wounds in groups C, XG, and 
XGL was accompanied by the presence of crust, infiltration of inflam-
matory cells, angiogenesis, collagen impregnation, formation of granu-
lation tissue, and re-epithelialization of the lesion (Figure 5). 
On the third day after surgery, group C showed the presence of a 
crust consisting of plasma and cellular debris occupying the most su-
perficial region of the lesion, with the presence of a mild inflammatory 
infiltrate. On the other hand, the XG group presented in addition to the 
crust and intense inflammatory infiltrate, a clear angiogenesis. The XGL 
group, in addition to the elements already mentioned for the other 
groups, also observed the presence of fibroblasts. These data indicate 
that both groups XG and XGL already showed signs of advanced healing 
with three days of treatment when compared to group C. The presence of 
inflammatory cell, mainly macrophage, is fundamental to the healing 
process allowing the degradation and elimination of damaged compo-
nents from extracellular matrix (ECM) in epithelial tissue, such as 
collagen and elastin (Singer & Clark, 1999). 
On the sixth day, it was still possible to observe the presence of in-
flammatory cells and a dense crust. However, the XG group has already 
started to present fibrovascular granulation tissue and a thinner crust. As 
for the XGL group, in addition to fibrovascular granulation tissue, it was 
possible to observe an intense collagen deposition and vascular neo-
formation, indicating that this group with six days of treatment was 
already in the proliferative phase of the healing process (Singer & Clark, 
1999; Tottoli et al., 2020). During this phase, metalloproteinases (MMP) 
are the main components of the ECM responsible for the proteolytic 
remodeling process of damage tissues (Gearing et al., 1994). These en-
zymes can be produced by several types of skin cells, such as fibroblasts, 
endothelial cells, mast cells and polymorphonuclear cells, having an 
important role in various physiological situations, including: morpho-
genesis, tissue development, tissue repair and angiogenesis (Kähäri & 
Saarialho-Kere, 1997). Previous works, reported that ConA can induce 
the production of MMP-9 by lymphocytes, witch in association with 
other MMP from ECM can improve the healing process (Dubois et al., 
1998; Silva et al., 2009). 
On the tenth day, it was possible to observe the maturation of 
granulation tissue and the beginning of collagen deposition for groups C 
and XG, however the XGL group already shown a reduction in collagen 
deposition, thus characterizing the beginning of the remodeling and 
reepithelization phase of the injury. On the fourteenth day, collagen 
Table 2 
Kinetics parameters of ConA release fitted four mathematical models.  
Units Zero order First order Higuchi Korsmeyer- 
Peppas 
Kinetic constants 1.04 0.02 11.00 7.34 
Correlation 
coefficient 
0.90 0.66 0.95 0.98 
Release exponent - - - 0.58  
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deposition in group C was still visible, but groups XG and XGL already 
had a well-organized ECM with the presence of newly formed vessels, 
dermal attachments and well-stratified epithelial tissue. Xyloglucan 
membranes with and without Cramoll lectin, after 12 days, in a daily 
treatment of cutaneous wounds of diabetic mice, could accelerate the 
wound reepithelization with typical characteristics of healthy skin 
(Andrade et al., 2021). Although the wounds were performed in health 
mice, our work showed similar results despite a unique application of 
the dressings XG and XGL. 
3.4.1. Cytokines profile 
The cytokines profile identified in the serum of animals treated with 
XG and XGL, in addition to control group, are presented in Figure 6. 
During the in vivo wound healing experiment, the immunomodulation of 
the cytokines mobilized during the treatments were evaluated in terms 
of the inflammation response by the production of pro-inflammatory 
cytokines like interferon-γ (IFN-γ), tumour necrosis factor (TNF-α), 
interleukin 1β (IL-1β), interleukin 6 (IL-6), and interleukin 12 (IL-12). 
IFN-γ is a major cytokine that plays a key role in innate and adaptive 
immune responses (Biringanine et al., 2005). Regarding the results for 
IFN-γ, it was possible to observe that XG and XGL significantly reduced 
Fig. 4. Wound contraction rate of the macroscopic measurements (A) and the wound imaging of circular excision wound areas at 0, 3rd, 6th, 10th and 14th days (B). C: 
control (saline); XG: xyloglucan dressing; XGL: xyloglucan dressing containing ConA. The wound area was expressed by the means±standard deviation (n=3) and the 
statistic analysis performed by ANOVA followed by the Tukey test (*p<0.05). 
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the production of interferon from 0th to 10th day when compared to the 
negative control group; in addition, no difference was observed between 
the XG and XGL treatments for the entire experimental range. The same 
pattern of significant decrease in cytokine secretion was observed for 
TNF-α on specific days. TNF-α is a cytokine produced by mono-
cytes/macrophages in a cellular concentration-dependent manner. It is 
Fig. 5. Histologic photomicrograph of skin wounds of mice from control (C), xyloglucan dressing (XG) and xyloglucan dressing containing ConA (XGL) groups at 3rd, 
6th, 10th and 14th of treatment, stained with Masson’s trichrome. Scale bar: 100 µm. Legend: c: crust; i: inflammatory infiltrate; ta: transition area; a: angiogenesis; r: 
re-epithelialization; fv: fibrovascular granulation tissue; ep: stratified epidermis; arrow: fibroblasts; asterisk: collagen fibers. 
Fig. 6. Cytokine profile of the wound healing process at the day of the surgery and after 3rd, 6th, 10th and 14th day. C: control (saline); XG: xyloglucan dressing; XGL: 
xyloglucan dressing containing ConA. The results were expressed as the mean±standard deviation (n=3) and the statistic analysis performed by ANOVA followed by 
the Bonferroni test (*p<0.05). 
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effective in regulating inflammation and autoimmunity, especially due 
to the ability to activate NK cells. Our results demonstrate that XGL 
decreased TNF-α secretion when compared to the control group from the 
3rd day and it was also possible to observe statistical differences between 
XG and XGL treated groups at 0th, 6th, 10th, and 14th days. In this case, 
the immunomodulatory activity of ConA from the XGL films is 
congruent with what has been reported for mannose binding lectins, i.e., 
the lectinś capability to reduce the pro-inflammatory cytokine produc-
tion, mainly TNF-α and IL-10 (Silva et al., 2016). 
Interleukins, like IL-1β, IL-6, and IL-12, are pro-inflammatory cyto-
kines generated by a variety of immune cells, which regulate the cellular 
interaction between leucocytes and other cells. They are involved in 
maintaining body homeostasis against infections (Huang et al., 2019). 
The IL-1β secretion was significantly decreased by XGL treatment from 
6th to 10th days in comparison with both XG and the control groups. The 
serum level of IL-6 was detected only between the 3rd and 10th day, 
especially when the inflammatory and remodelling phase of the healing 
process is on the peak (Tottoli et al., 2020). In this period, XG and XGL 
treatments were different from the control group, proving its 
anti-inflammatory activities and corroborating the histologic analysis. 
Only in the remodelling phase (from the 6th to 10th days) that the levels 
of IL-6 showed difference between the XG and XGL treatments. In the 
peak of the inflammatory phase (3rd day), it was also observed a sig-
nificant reduction in the serum level of IL-12 for the animals treated with 
the XG and XGL films. These results urging that the XDL possess a good 
anti-inflammatory activity during the healing process, especially in the 
early phase, which is a top priority characteristic in the field of 
dressings. 
From the 6th, no significant difference was observed on the serum 
level of IL-12 among the treated groups. During the inflammatory phase 
of the wound healing, occurs a M2 macrophage subset formation, which 
regulate inflammation by expressing cytokines as IL-1, IL-10, and IL-12, 
as well as several growth factors to promote fibroblast proliferation, 
extracellular matrix synthesis, and angiogenesis (Kotwal & Chien, 2017; 
Serra et al., 2017; Xiao et al., 2020). The non-reduction of IL-12 on the 
treated groups after the 6th day suggests that these M2 macrophage are 
contributing actively with the remodelling and reepithelization phase of 
the wound. 
3.4.2. Serum proteome 
Proteome profile on the 3rd day after surgery was performed to 
identify the serum proteins that were differentially expressed from the 
XGL group to the XG and control groups and that possessed a reported 
influence in stimulating the wound healing process. Seven expressed 
proteins were identified and characterized by proteomics analysis 
(Table 3) from the 2D gel electrophoretogram of the serum proteins 
(Supplementary material). The proteins that showed an increase 
expression were α1-antitrypsin, serine peptidase inhibitor, vitamin D- 
binding protein and hemopexin, while apolipoprotein A1, albumin and 
transferrin showed a decrease expression. These proteins are closely 
linked to the inflammatory phase of the healing process, playing several 
roles to delay the inflammation and pain and the tissue damage caused 
by the injury. 
It is known that, during inflammatory processes, HDL can undergo 
modifications and become pro-inflammatory (Ansell et al., 2007). 
Apolipoprotein A1 (spot 1) is the main component of HDL under normal 
conditions. However, during inflammatory events, its production can be 
suppressed by cytokines, and the apolipoprotein A1 containing lipids are 
rapidly catabolized, thus, promoting an anti-inflammatory response 
(Georgila, Vyrla, & Drakos, 2019). The decreased expression of apoli-
poprotein A1 in animals treated with XGL during the inflammatory 
phase of the wound, could be related to this phenomenon, which is 
beneficial to the healing process. 
During the inflammatory phase of the wound, the XGL treatment was 
not capable in maintain the serum levels of albumin (spot 2), and its 
decreased expression in comparison with the XG and control groups 
corroborates with a greater local protein catabolism that could be being 
stimulated by the XGL. The local proteolysis is an important debride-
ment event that occur during the inflammatory phase of the wound 
(Tottoli et al., 2020) and the devitalized tissue removal is a fundamental 
process for tissue repair (Lumbers, 2018). 
The α1-antitrypsin (spot 3), together with serine peptidase inhibitor, 
clade A (spot 4), had their expression increased during the inflammatory 
phase of the wound healing in the animals treated with XGL. The 
expression of serpins during inflammatory phase can increase the 
collagen type I production, accelerating the healing process and limiting 
the tissue damage caused by the wound (Congote et al., 2008; Lucas 
et al., 2018). The vitamin D binding protein (spot 5) is a circulating 
multifunctional plasma protein that can significantly enhance the 
chemotactic activity of neutrophil, modulating the immune system 
(Kew, 2019). Besides that, it plays an additional role in preventing the 
polymerization of actin, helping the body in the healing of damaged 
tissues (Meier et al., 2006). During the inflammatory phase of the wound 
healing, large quantities of actin from the tissue injury can be released 
into extracellular fluids where the protein escapes from normal intra-
cellular scavenger mechanisms and spontaneously form F-actin fila-
ments. Higher concentrations of F-actin filaments in plasma can induce 
microcirculatory diseases and to prevent the its accumulation, the 
vitamin D binding protein decrease the plasma concentration of free 
actin (Haddad et al., 1990; Meier et al., 2006). The treatment with the 
XGL increased the vitamin D binding protein expression during the in-
flammatory phase of the healing process proving its beneficial efficacy 
in the wound care. 
Hemopexin is a heme plasma glycoprotein which, after haptoglobin, 
acting as a second line of barrier against heme’s pro-inflammatory and 
pro-oxidant effects and increase its detoxification (Chen et al., 2020a; 
Kanno et al., 2017). The expression of hemopexin (spot 6) was 
up-regulated during the inflammatory phase (Table 3). These indicate 
that the XGL could be involved in an earlier anti-inflammatory response 
and the suppression of oxidative stress to accelerate the wound healing. 
Equally to serum albumin, transferrin (spot 7) is a negative acute phase 
protein, which expression decreased in the animals treated with the 
XGL. Transferrin is an iron-binding glycoprotein that control the level of 
free iron in biological fluids. Decrease plasma levels of transferrin lead to 
the iron excess in the extracellular matrix, which has a deleterious effect 
on tissue repair (Crichton & Charloteaux-Wauters, 1987; Recalcati et al., 
2019). To preventing this, activated M1-macrophages, during the in-
flammatory phase of the wound healing, plays an important role in the 
Table 3 
Mass spectrometric features of distinguished serum protein identified during the healing process of the animals treated with the xyloglucan dressing containing ConA 
(XGL) in comparison to the xyloglucan dressing (XG) and control (saline) groups on 3rd day after surgery.  
Spot Identity Score TheoreticalIsoelectricPoint MolecularWeight(kDa) Relative expression 
1 Apolipoprotein A1 precursor 165 5.52 30.3 decrease 
2 Serum albumin precursor 107 5.75 70.7 decrease 
3 α-1 antitrypsin (SERPIN-1) precursor 90 5.33 46.0 increase 
4 Serine (or cysteine) peptidase inhibitor clade A, member 3K 138 5.05 46.9 increase 
5 Vitamin D-binding protein 101 5.26 54.6 increase 
6 Hemopexin precursor 88 7.92 52.0 increase 
7 Serotransferrin precursor 106 6.94 78.8 decrease  
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iron metabolism (Recalcati, Locati, & Cairo, 2012). Iron sequestration 
by M1-macrophages is an efficient bacteriostatic effect in host defense 
(Ganz & Nemeth, 2015). Considering this, the modulation of important 
proteins expression in the tissue injury of the animals treated with XGL 
compared with the XG and control groups, could be explained by a 
non-contaminated, anti-inflammatory and accelerated healing 
promotion. 
4. Conclusion 
This work mainly addressed the relationships between physico-
chemical and morphological properties of a xyloglucan wound dressing, 
its capacity as biomolecule carrier and in vivo wound healing applica-
tion. The ConA incorporated in the xyloglucan dressing maintained its 
biological activity for fourteen days in a controlled-release manner. XG 
and XGL were non-toxic, homogeneous, easy to handle, and flexible, 
suggesting that it can provide a safe protection to the wound during 
healing. Although the XGL showed a better wound contraction 
compared with the XG, both were capable of accelerate the wound 
healing, promoting less infiltration of inflammatory cells, more angio-
genesis, remodeling, and early epithelization. Further, both films alle-
viate the inflammation phase by reducing the production of pro- 
inflammatory cytokines, like IL-1β, IL-6, IL-12, INF-γ, and TNF-α. The 
XGL also showed a good healing activity in promote the up- and down- 
regulation of important proteins associated in the wound repair. Finally, 
all these findings suggest that both XG and XGL may represent a good 
therapeutic approach for advanced wound healing applications. 
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Cevher, E. (2019). An alternative approach to wound healing field; new composite 
films from natural polymers for mupirocin dermal delivery. Saudi Pharmaceutical 
Journal, 27(5), 738–752. https://doi.org/10.1016/j.jsps.2019.04.010. 
Valenga, F., Petri, D. F. S., Lucyszyn, N., Jó, T. A., & Sierakowski, M. R. (2012). 
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